09:02 IST
BSE
Business UpdateCipla Ltd CIPLA
Cipla Business Update
Cipla's subsidiary InvaGen received zero Form 483 observations in a routine USFDA cGMP inspection. The clean outcome confirms compliance at its US manufacturing facility.